FMO5 and glioma: Remarkably, treatment with the ROS inhibitor apocynin (a NADPH oxidase inhibitor) significantly reduced the migratory and invasive capacity of U251 glioma cells under hypoxia in parallel to the pharmacologic concentration of melatonin.